tbuckley/cabot-search huggingface dataset:
Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study): a cluster-randomised, multicentre, crossover study
Authors: Deverick J Anderson, Luke F Chen, David J Weber, Rebekah W Moehring, Sarah S Lewis, Patricia F Triplett, Michael Blocker, Paul Becherer, J Conrad Schwab, Lauren P Knelson, Yuliya Lokhnygina, William A Rutala, Hajime Kanamori, Maria F Gergen, Daniel J Sexton
Journal: The Lancet (2017)
CHAPTER VIII: Perfusion Lung Scanning
Journal: Circulation (1973)

Lung scans at 24 hours after the onset of infusion indicated that restoration of pulmonary arterial blood flow was more rapid in patients who received a 12-hour urokinase infusion than in patients treated with heparin alone. Patients with recent emboli (less than 48 hours old) appeared to respond better to urokinase than patients with older emboli (48 hours to 6 days old). After 7 days, there was no difference in lung scan resolution between the urokinase and the heparin patients, and both groups showed progressive lung scan improvement for approximately 3 months. Regardless of treatment, prominent residual scan defects (≥10%) remained in 16% of the patients at the end of a year. Six of the 17 patients with such defects had a history of pulmonary embolism preceding the event that brought them into this Trial.
First Report On the H10 EORTC/GELA/IIL Randomized Intergroup Trial On Early FDG-PET Scan Guided Treatment Adaptation Versus Standard Combined Modality Treatment in Patients with Supra-Diaphragmatic Stage I/II Hodgkin's Lymphoma, for the Groupe d'Etude Des Lymphomes De l'Adulte (GELA), European Organisation for the Research and Treatment of Cancer (EORTC) Lymphoma Group and the Intergruppo Italiano Linfomi (IIL).
Authors: Marc PE André, Oumédaly Reman, Massimo Fédérico, Pauline Brice, Ercole Brusamolino, Théodore Girinski, Christophe Ferme, Richard vander Maazen, Monica Bellei, Catherine Sebban, Franck Morschhauser, Elly Lugtenburg, Aspasia Stamatoullas, Liliana Baila, Catherine Fortpied, Michel Meignan, John M. Raemaekers
Journal: Blood (2009)
Predictors for the Efficacy of Peripheral Blood Progenitor Cell (PBPC) Collection–Results from 4050 Harvests Performed in a Single Centre
Authors: Kristina Hoelig, Frank Kroschinsky, Michael Kramer, Matthias Blechschmidt, Kristin Zimmer, Uta Oelschlaegel, Claudia Rutt, Martin Bornhaeuser, Gerhard Ehninger
Journal: Blood (2008)
Quantifying Disease Progression in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
Authors: Wojciech Zareba
Journal: JAMA Cardiology (2017)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Cardiology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Cardiology journal
Rituximab + ABVD Improves Event-Free Survival (EFS) in Patients with Classical Hodgkin Lymphoma in All International Prognostic Score (IPS) Groups and in Patients Who Have PET Positive Disease after 2–3 Cycles of Therapy.
Authors: Amanda R. Wedgwood, Michelle A. Fanale, Luis E. Fayad, Peter McLaughlin, Fredrick B. Hagemeister, Barbara Pro, Jorge Romaguera, Maria A. Rodriguez, Felipe Samaniego, Anas Younes
Journal: Blood (2007)
CD33-Negative Acute Myeloid Leukemia (AML) Has Similar Characteristics to CD33-Positive Disease.
Authors: Cecilia Y. Arana Yi, Wei Tan, Gregory Wilding, Laurie Ann Ford, Sheila N.J. Sait, AnneMarie W. Block, George Deeb, Paul K. Wallace, Petr Starostik, James E. Thompson, Eunice S. Wang, Meir Wetzler
Journal: Blood (2009)
Combined Disruptions of the Ribosomal Protein s19 and Pim1 Kinase Genes Are Associated with Increased Myeloid/Erythroid Cellularity and Reduced Apoptosis
Authors: Anne-Sophie Fröjmark, Jitendra Badhai, Jens Schuster, Joakim Klar, Maria Thuvesson, Steven Ellis, Niklas Dahl
Journal: Blood (2008)
Reply to L.B. Marks et al
Authors: Abram Recht, Elizabeth A. Comen, Richard E. Fine, Gini F. Fleming, Patricia H. Hardenbergh, Alice Y. Ho, Clifford A. Hudis, E. Shelley Hwang, Jeffrey J. Kirshner, Monica Morrow, Kilian E. Salerno, George W. Sledge, Lawrence J. Solin, Patricia A. Spears, Timothy J. Whelan, Mark R. Somerfield, Stephen B. Edge
Journal: Journal of Clinical Oncology (2017)
Ultra-Violet Rays in the Treatment and Cure of Disease.
Journal: JAMA (1926)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Source of Ectopic ACTH Secretion Easily Identified by 68 Ga DOTANOC PET/CT
Authors: Sofiullah Abubakar, Yaw Ampem Amoako, Tessa Kotze, Naima Tag
Journal: Clinical Nuclear Medicine (2017)

Malignant tumors account for most sources of ectopic ACTH Cushing syndrome (EA-CS). Early localization of the source and complete removal can be curative and also prevent metastasis. Diagnostic CT is known to perform better than PET/CT (low dose) in characterizing lung pathologies. However, bronchial carcinoids, a common source of EA-CS, may be difficult to detect on chest CT scan especially when it is small and located close to the hilar region. We present a case of EA-CS due to bronchial carcinoid, which was easily seen on Ga DOTANOC PET/CT after a diagnostic chest CT was reported as normal.
Value of Neoadjuvant Chemotherapy for Newly Diagnosed Advanced Ovarian Cancer: A European Perspective
Authors: Christina Fotopoulou, Jalid Sehouli, Giovanni Aletti, Philipp Harter, Sven Mahner, Denis Querleu, Luis Chiva, Hani Gabra, Nicoletta Colombo, Andreas du Bois
Journal: Journal of Clinical Oncology (2017)
Levels of Circulating Alternatively Spliced Tissue Factor (asTF) in the Plasma of Patients with Pancreatic Ductal Adenocarcinoma (PDAC) May Help Predict Aggressive Tumor Phenotype
Authors: Dusten Unruh, Farah Sagin, Mariette Adam, Patrick Van Dreden, Barry J Woodhams, Syed A Ahmad, Vladimir Y Bogdanov
Journal: Blood (2014)
The Affordable Care Act Medicaid Expansion Correlated With Increased Heart Transplant Listings in African-Americans But Not Hispanics or Caucasians
Authors: Khadijah Breathett, Larry A. Allen, Laura Helmkamp, Kathryn Colborn, Stacie L. Daugherty, Prateeti Khazanie, Richard Lindrooth, Pamela N. Peterson
Journal: JACC Heart Failure (2017)
Cholesterol-lowering drugs: science and marketing
Authors: Livio Garattini, Anna Padula
Journal: Journal of the Royal Society of Medicine (2017)

Long-term use of statin therapy is essential to obtain clinical benefits, but adherence is often suboptimal and some patients are also reported to fail because of ‘statin resistance'. The identification of PCSK9 as a key factor in the LDL clearance pathway has led to the development of new monoclonal antibodies. Here we critically review the economic evaluations published in Europe and focused on statins. We searched the PubMed database to select the studies published from July 2006 to June 2016 and finally selected 19 articles. Overall, the majority of studies were conducted from a third-party payer's viewpoint and recurred to modelling. Most studies were sponsored by industry and funding seemed to play a pivotal role in the study design. Patients resistant to LDL-C level reduction were considered only in a few studies. The place in therapy of the new class of biologic should be considered a kind of ‘third line' for cholesterol-lowering, after patients have failed with restricted dietary regimens and then with current drug therapies. Otherwise they could result in hardly sustainable expenses even for developed countries.
Erratum to: Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors
Authors: Georgina L. Ryland, Sally M. Hunter, Maria A. Doyle, Franco Caramia, Jason Li, Simone M. Rowley, Michael Christie, Prue E. Allan, Andrew N. Stephens, David D. L. Bowtell, Ian G. Campbell, Kylie L. Gorringe
Journal: Genome Medicine (2017)

ERRATUM: There is an error in Additional file 2 for this article [1]. When opening Additional file 2, this links to the incorrect file. NOTES: The online version of the original article can be found at http://dx.doi.org/10.1186/s13073-015-0210-y.
ADDITIONAL FILES: Additional file 2: Figure S1. Nucleotide substitution frequency and context. Figure S2. RRAS2 somatic mutation. Figure S3. Genetic comparison between mucinous ovarian tumors and mucinous cancers from other anatomical sites. Figure S4. ELF3 somatic mutations. Figure S5. H&E stained sections of frozen tissues used for exome discovery cohort.
XmAb™ Fc Engineered Anti-CD19 Monoclonal Antibody with Enhanced In Vitro Efficacy Against Lymphoma and Leukemia.
Authors: Eugene Zhukovsky, Seung Chu, Matthew Bernett, Sher Karki, John Richards, Erik Pong, Matthias Peipp, Roland Repp, John Desjarlais
Journal: Blood (2007)
Multivariate Analysis Suggests That the Prognostic Impact of Poor Cytogenetics Is Potentially Underestimated in the IPSS.
Authors: Julie Schanz, Elihu H. Estey, Christian Steidl, Ulrich Germing, Barbara Hildebrandt, Guillermo Garcia-Manero, Hagop M. Kantarjian, Detlef Haase
Journal: Blood (2007)
The Dual Endothelin Receptor Antagonist Bosentan Prevents the Acute Sickle Cell-Related Hypoxic Lung and Kidney Injury in Transgenic SAD Mice.
Authors: Nathalie Sabaa, Lucia de Franceschi, Philippe Bonnin, Giorgio Malpeli, Stéphane Germain, Sophie Vandermeersch, Micheline Maier-Redelsperger, Aldo Scarpa, Anne Janin, Bernard Levy, Robert Girot, Yves Beuzard, Christophe Leboeuf, Annick Henri, Jean-Claude Dussaule, Pierre-Louis Tharaux
Journal: Blood (2006)
Results of Immunosupresive Therapy in Children with Aquired Severe Aplastic Anaemia (SAA). Report Polish Pediatric Hematology Group
Authors: Katarzyna Pawelec, Edyta Niewiadomska, Michal Matysiak, Jerzy Kowalczyk, Jolanta Stefaniak, Walentyna Balwierz, Ewa Zaleska-Czepko, Alicja Chybicka, Krzysztof Szmyd, Danuta Sonta-Jakimczyk, Halina Bubala, Mariusz Wysocki, Andrzej Kurylak, Jacek Wachowiak, Grzegorz Grund, Wojciech Mlynarski, Monika Bulas, Maryna Krawczuk-Rybak, Elzbieta Leszczynska, Tomasz Urasinski, Jaroslaw Peregud-Pogorzelski
Journal: Blood (2008)
Complete and Very Good Partial Responses Are Attainable Endpoints in Elderly Patients (&gt;75 years) with AL Amyloidosis and Are Associated with Improved Overall Survival,
Authors: Christopher P. Venner, Julian D Gillmore, Thirusha Lane, Darren Foard, Lisa Rannigan, Simon DJ Gibbs, Jennifer Pinney, Carol Whelan, Helen Lachmann, Philip N Hawkins, Ashutosh Wechalekar
Journal: Blood (2011)
The Importance of Long-term Follow-up Within Randomized Clinical Trials of Cardiovascular Devices
Authors: Ajay J. Kirtane, Robert O. Bonow
Journal: JAMA Cardiology (2017)

Clemens von Birgelen, MD, PhD; Liefke C. van der Heijden, MD; Mounir W. Z. Basalus, MD, PhD; Marlies M. Kok, MD; Hanim Sen, MD, PhD; Hans W. Louwerenburg, MD; K. Gert van Houwelingen, MD; Martin G. Stoel, MD, PhD; Frits H. A. F. de Man, MD, PhD; Gerard C. M. Linssen, MD, PhD; Kenneth Tandjung, MD, PhD; Carine J. M. Doggen, PhD; Job van der Palen, PhD; Marije M. Löwik, PhD
Molecular and Cytogenetic Response After 3 Months of Imatinib Treatment Is Predictive for the Risk of Disease Progression and Death in Newly Diagnosed Chronic Myeloid Leukemia Patients – a Follow-up Analysis of the German CML Study IV
Authors: Benjamin Hanfstein, Martin C. Müller, Philipp Erben, Michael Lauseker, Susanne Saussele, Ulrike Proetel, Susanne Schnittger, Claudia Haferlach, Hans-Jochem Kolb, Stefan W. Krause, Christoph Nerl, Dominik Heim, Gabriela M. Baerlocher, Jörg E. A. Schubert, Hermann Einsele, Mathias Hänel, Jolanta Dengler, Christiane Falge, Lothar Kanz, Andreas Neubauer, Michael Kneba, Frank Stegelmann, Michael Pfreundschuh, Cornelius F. Waller, Markus Pfirrmann, Jörg Hasford, Wolf-Karsten Hofmann, Rüdiger Hehlmann, Andreas Hochhaus
Journal: Blood (2011)
The PI3K Inhibitor GS-1101 (CAL-101) Synergistically Potentiates HDAC-Induced Proliferation Inhibition and Apoptosis Through the Activation of JNK in Lymphoma Cells
Authors: Juraj Bodo, Brian T. Hill, Xiaoxian Zhao, Craig A. Portell, Brian J. Lannutti, Eric D. Hsi
Journal: Blood (2012)
Aldehyde Dehydrogenase 3a2 (Aldh3a2) Represents a Distinct Metabolic Vulnerability in MLL-AF9 AML Leukemia Initiating Cells
Authors: Rushdia Z. Yusuf, Sanket S. Acharya, Vionnie W.C. Yu, Borja Saez, Julien M Cobert, John Doench, Lars Bullinger, Dana S'aulis, Dongjun Lee, Rahul Palchaudhuri, Akachimere C. Uzosike, Mildred Duvet, David J. Logan, Sudeshna Das, Colleen M Cook, Michael Churchill, Elizabeth Scadden, Gohar Warraich, Hao Liu, Shrikanta Chattopadhyay, Adam Brown, Stephen M. Sykes, David B. Sykes, Francois Mercier, Anne E. Carpenter, Scott A. Armstrong, Matthew Vander Heiden, Benjamin L. Ebert, Andrew L. Kung, William B. Rizzo, Siddhartha Mukherjee, David T. Scadden
Journal: Blood (2012)
The Prognostic Importance of T and NK-Cells in a Consecutive Series of Newly Diagnosed Patients with Chronic Lymphocytic Leukemia.
Authors: Shanique Palmer, Curtis A. Hanson, Clive S. Zent, Louis F. Porrata, Betsy LaPlant, Susan M. Geyer, Svetomir N. Markovic, Timothy G. Call, Deborah A. Bowen, Diane F. Jelinek, Neil E. Kay, Tait D. Shanafelt
Journal: Blood (2007)
Root canal morphology and configuration of 123 maxillary second molars by means of micro-CT
Authors: Thomas Gerhard Wolf, Frank Paqué, Anja-Christin Woop, Brita Willershausen, Benjamín Briseño-Marroquín
Journal: International Journal of Oral Science (2017)

The aim of this study was to investigate the root canal configuration, accessory canals and number of main foramina of 123 maxillary second molars by means of micro-computed tomography. The teeth were scanned and reproduced with 3D software imaging. The root canal configuration and number of main foramina were evaluated by means of a four-digit system. The morphological complexity of human maxillary second molars is depicted by the number of accessory and connecting canals. The most frequently observed root canal configurations in the mesiobuccal root were 2-2-2/2 (19.5%), 2-2-1/1 (14.6%) and 2-1-1/1 (13.0%). A 1-1-1/1 configuration was observed in 93.5% and in 96.7% in the distobuccal and palatal roots, respectively. The MB1 root canal had one accessory canal (18.7%), and 8.9% of the MB2 root canal had one or two accessory canals. The distobuccal (11.3%) and palatal (14.6%) root canals had at least one accessory canal, and connecting canals were observed in 16.3% of mesiobuccal roots. The MB1, MB2, distobuccal and palatal root canals had one main foramen in 99.2%, 43.1%, 98.4% and 99.2% of samples, respectively. In the mesiobuccal root, one accessory foramen was detected in 14.6%, two were detected in 7.3%, and three were detected in 5.7%. The distobuccal root showed one or two accessory foramina in 9.1% of samples. The root canal configuration of maxillary second molars is quite heterogeneous; the mesiobuccal root has predominantly two root canal entrances (58.4%, 1 in 41.1%) with one main foramen (54.4%). Two main foramina were observed in 43.0%. Morphological variations, connecting and accessory canals were observed in all apical thirds.
HLA-Dependent Immune Selection Pressure on the Idiotype Is Predominantly Driven by Somatic Hypermutation In Malignant Lymphoma but Also Modulates Vh Usage In Normal B Cells
Authors: Dimitrios Papaioannou, Anna-Maria Strothmeyer, Marcus Dühren-von Minden, Marcelo A. Navarrete, Katja Zirlik, Kristina Heining-Mikesch, Hendrik Veelken
Journal: Blood (2010)
Active Electrodes for Wearable EEG Acquisition: Review and Electronics Design Methodology
Authors: Jiawei Xu, Srinjoy Mitra, Chris Van Hoof, Refet Firat Yazicioglu, Kofi A. A. Makinwa
Journal: IEEE Reviews in Biomedical Engineering (2017)

Active Electrodes (AE), i.e. electrodes with built-in readout circuitry, are increasingly being implemented in wearable healthcare and lifestyle applications due to AE's robustness to environmental interference.An AE locally amplifies and buffers µV-level EEG signals before driving any cabling.The low output impedance of an AE mitigates cable motion artifacts thus enabling the use of high-impedance dry electrodes for greater user comfort.However, developing a wearable EEG system, with medical grade signal quality on noise, electrode offset tolerance, common-mode rejection ratio (CMRR), input impedance and power dissipation, remains a challenging task.This paper reviews state-of-the-art bio-amplifier architectures and low-power analog circuits design techniques intended for wearable EEG acquisition, with a special focus on AE system interfaced with dry electrodes. Index Terms-Active electrode, instrumentation amplifier (IA), electroencephalography (EEG), dry electrodes, common-mode rejection ratio (CMRR), brain-computer interface (BCI) I. INTRODUCTIONecent advances in biomedical technologies, integrated circuits (ICs), sensors and data analysis techniques have accelerated the development of wearable technology for Telehealth applications.Today, miniature and low-power medical sensors can be easily integrated into various accessories that continuously sense, process and transfer people's physiological information during their daily life activities.By reducing the need for manual intervention and by lowering the cost, these medical devices are being widely used in personal healthcare and home diagnostics, such as wellness and health monitoring, home rehabilitation, and the early detection of brain disordersElectroencephalography (EEG) is one of the most important methods to monitor the electrical behaviors of the brain and to evaluate brain disorders.In recent years, the growing need for continuous and comfortable brain activities monitoring have promoted the development of wearable EEG devices for both clinical and non-clinical applications [3]-[5], from deep sleep monitoring, epileptic seizure detection, mental state analysis, to
Buccal Mucosa Cells Are Unsuitable As a Control Tissue to Distinguish Somatic Hematopoietic Mutations From Germline Mutations: Nail DNA Is a Suitable Surrogate
Authors: Donna M. Williams, Ophelia Rogers, D. Treva Rowley, Josef T. Prchal, Jerry L. Spivak, Alison R. Moliterno
Journal: Blood (2011)
Genetic variation and gene expression across multiple tissues and developmental stages in a nonhuman primate
Authors: Anna J Jasinska, Ivette Zelaya, Susan K Service, Christine B Peterson, Rita M Cantor, Oi-Wa Choi, Joseph DeYoung, Eleazar Eskin, Lynn A Fairbanks, Scott Fears, Allison E Furterer, Yu S Huang, Vasily Ramensky, Christopher A Schmitt, Hannes Svardal, Matthew J Jorgensen, Jay R Kaplan, Diego Villar, Bronwen L Aken, Paul Flicek, Rishi Nag, Emily S Wong, John Blangero, Thomas D Dyer, Marina Bogomolov, Yoav Benjamini, George M Weinstock, Ken Dewar, Chiara Sabatti, Richard K Wilson, J David Jentsch, Wesley Warren, Giovanni Coppola, Roger P Woods, Nelson B Freimer
Journal: Nature Genetics (2017)
PanIN Neuroendocrine Cells Promote Tumorigenesis via Neuronal Cross-talk
Authors: Smrita Sinha, Ya-Yuan Fu, Adrien Grimont, Maren Ketcham, Kelly Lafaro, Joseph A. Saglimbeni, Gokce Askan, Jennifer M. Bailey, Jerry P. Melchor, Yi Zhong, Min Geol Joo, Olivera Grbovic-Huezo, In-Hong Yang, Olca Basturk, Lindsey Baker, Young Park, Robert C. Kurtz, David Tuveson, Steven D. Leach, Pankaj J. Pasricha
Journal: Cancer Research (2017)

Nerves are a notable feature of the tumor microenvironment in some epithelial tumors, but their role in the malignant progression of pancreatic ductal adenocarcinoma (PDAC) is uncertain. Here, we identify dense innervation in the microenvironment of precancerous pancreatic lesions, known as pancreatic intraepithelial neoplasms (PanIN), and describe a unique subpopulation of neuroendocrine PanIN cells that express the neuropeptide substance P (SP) receptor neurokinin 1-R (NK1-R). Using organoid culture, we demonstrated that sensory neurons promoted the proliferation of PanIN organoids via SP-NK1-R signaling and STAT3 activation. Nerve-responsive neuroendocrine cells exerted trophic influences and potentiated global PanIN organoid growth. Sensory denervation of a genetically engineered mouse model of PDAC led to loss of STAT3 activation, a decrease in the neoplastic neuroendocrine cell population, and impaired PanIN progression to tumor. Overall, our data provide evidence that nerves of the PanIN microenvironment promote oncogenesis, likely via direct signaling to neoplastic neuroendocrine cells capable of trophic influences. These findings identify neuroepithelial cross-talk as a potential novel target in PDAC treatment. Cancer Res; 77(8); 1868–79. ©2017 AACR.
Risk Factors and Survival Analyses of Ocular Graft-Versus-Host Disease (GVHD) in the Current Era of Allogeneic Stem Cell Transplant (SCT).
Authors: Madan Jagasia, Sunny Mehrotra, Vinita Singh, Adetola A. Kassim, Brian Engelhardt, Sheri Dixon, Uyen Tran
Journal: Blood (2008)
Allogeneic Stem Cell Transplantation for Sickle Cell Disease in Brazil: The Time Is Now!
Authors: Belinda Pinto Simoes, George B Navarro, Fabiano Pieroni, Luiz G Darrigo, Daniela Moraes, Ana Beatriz PL Stracieri, Juliana F Fernandes, Carmem Bonfim, Gustavo Machado Teixeira, Francisco J P Aranha, Júlio C. Voltarelli
Journal: Blood (2011)